The Iron Lung: Ferroptosis and Iron Regulation in Aging and Lung Diseases
Physiology · 2027
DOI: 10.1152/physiol.00062.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiology, 2027. Verfasst von Maunick Lefin Koloko Ngassie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States. Hauptthemen laut MEDLINE: Iron, Aging, Lung Diseases, Ferroptosis. Die Arbeit nennt 194 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NHLBI NIH HHS, American Heart Association (AHA).
Abstract (Originalsprache)
Iron is an important metal element regulating biological processes such as gene expression, electron transport, cell proliferation, differentiation and division, and cellular respiration. Regulation of iron levels is therefore critical, with excess iron accumulation leading to iron-dependent lipid peroxidation and cell death (ferroptosis). Factors such as aging and environmental exposures (e.g., high/low oxygen, particulate iron) can disrupt iron homeostasis. Iron-dependent processes influence downstream pathways such as inflammation, mitochondrial energetics, and remodeling (proliferation, fibrosis), pathways involved in lung diseases particularly at the extremes of age, from hyperoxic lung injury in neonates to chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis (PF) that increase with age. Although these diseases involve structural and functional changes in bronchial versus alveolar compartments, including airway hyperreactivity, altered mucus production, cell proliferation and migration, increased extracellular matrix (ECM) remodeling, senescence, and metabolic dysregulation, the casual or consequential links between iron dysregulation and disease pathology, particularly with aging, are still being investigated. The aim of this topical review is to 1) highlight current knowledge regarding iron regulation in normal lung versus lung diseases, 2) identify known roles of iron in lung homeostasis and the contribution of iron dysregulation in lung diseases with aging, and 3) explore the potential benefit of targeting iron regulation and/or ferroptosis in lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States.
- Physiology & Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, United States.
ORCID-Profile: Maunick Lefin Koloko Ngassie, Yamillie Ortiz, Preetham Ravi, Daniel A Pfeffer-Kleemann, Niyati A Borkar, Christina M Pabelick, Y S Prakash
Förderung
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- NHLBI NIH HHS
- American Heart Association (AHA)
Zitieren
APA
Koloko Ngassie, M. L., Ortiz, Y., Ravi, P., Pfeffer-Kleemann, D. A., Borkar, N. A., Pabelick, C. M., & Prakash, Y. S. (2027). The Iron Lung: Ferroptosis and Iron Regulation in Aging and Lung Diseases. Physiology. https://doi.org/10.1152/physiol.00062.2025
Vancouver
Koloko Ngassie ML, Ortiz Y, Ravi P, Pfeffer-Kleemann DA, Borkar NA, Pabelick CM, et al. The Iron Lung: Ferroptosis and Iron Regulation in Aging and Lung Diseases. Physiology. 2027. doi:10.1152/physiol.00062.2025
BibTeX
@article{KolokoNgassie2027,
author = {Koloko Ngassie, Maunick Lefin and Ortiz, Yamillie and Ravi, Preetham and Pfeffer-Kleemann, Daniel A and Borkar, Niyati A and Pabelick, Christina M and Prakash, Y S},
title = {The Iron Lung: Ferroptosis and Iron Regulation in Aging and Lung Diseases},
journal = {Physiology},
year = {2027},
doi = {10.1152/physiol.00062.2025}
}
EUVIMED